Dermatology Hospital of Southern Medical University
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo | Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo | Active, not recruiting | Phase 3 | 2026-09-28 | NCT06163326 | |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) | Plaque Psoriasis | Recruiting | Phase 3 | 2026-09-22 | NCT07116967 | |
| Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis | Prurigo Nodularis (PN) | Recruiting | Phase 2 | 2026-09-14 | NCT07236099 | |
| A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis | Plaque Psoriasis | Recruiting | Phase 3 | 2026-09-09 | NCT07250802 | |
| A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 | Active Nonsegmental Vitiligo; Stable Nonsegmental Vitiligo | Active, not recruiting | Phase 3 | 2026-06-24 | NCT06072183 | |
| Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study | Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous lupus erythematosus, skin disorder | Recruiting | Phase 2 | 2026-06-08 | NCT07440537 | |
| A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis | Moderate-to-severe Atopic Dermatitis | Active, not recruiting | Phase 2 | 2026-06-04 | NCT07321951 | |
| A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis | Plaque Psoriasis | Active, not recruiting | Phase 3 | 2026-06-02 | NCT06550076 | |
| Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria | Chronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Recruiting | Phase 2 / Phase 3 | 2026-04-21 | NCT07378527 | |
| A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis | Moderate-to-severe Atopic Dermatitis | Recruiting | Phase 2 | 2026-04-08 | NCT07211542 | |
| Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis | Plaque Psoriasis Patients | Recruiting | Phase 3 | 2026-02-09 | NCT06842199 | |
| ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 3 | 2025-09-08 | NCT06775860 |